Analysts Set Pediatrix Medical Group, Inc. (NYSE:MD) Target Price at $17.08

Pediatrix Medical Group, Inc. (NYSE:MD) has earned an average recommendation of “Hold” from the six research firms that are covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $17.08.

MD has been the topic of a number of analyst reports. Macquarie began coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 target price on the stock. Truist Financial increased their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research note on Friday, February 21st. UBS Group lifted their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. Finally, StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd.

Hedge Funds Weigh In On Pediatrix Medical Group

Institutional investors have recently modified their holdings of the business. Nomura Asset Management Co. Ltd. boosted its holdings in shares of Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock worth $33,000 after buying an additional 1,220 shares during the last quarter. Quest Partners LLC boosted its stake in Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after acquiring an additional 622 shares during the last quarter. Parkside Financial Bank & Trust grew its position in shares of Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after acquiring an additional 1,040 shares during the period. Quarry LP increased its stake in shares of Pediatrix Medical Group by 54.1% during the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,662 shares during the last quarter. Finally, AlphaQuest LLC raised its holdings in shares of Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock worth $66,000 after purchasing an additional 2,012 shares during the period. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Trading Down 0.8 %

NYSE MD opened at $14.12 on Friday. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $17.67. The business has a 50 day moving average price of $14.28 and a 200-day moving average price of $13.49. The company has a market cap of $1.21 billion, a price-to-earnings ratio of -11.76, a P/E/G ratio of 1.74 and a beta of 1.49.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The business had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. As a group, equities analysts expect that Pediatrix Medical Group will post 1.38 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.